COMMUNIQUÉS West-GlobeNewswire

Atara Biotherapeutics Announces Presentation of Initial ATA188 Phase 1 Safety Results for Patients with Progressive Multiple Sclerosis at the 5th Congress of the European Academy of Neurology (EAN)
15/05/2019
SOUTH SAN FRANCISCO, Calif., May 15, 2019 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with [...]
Tecan to present at upcoming Investor Conferences in the United States
15/05/2019
Männedorf, Switzerland, May 15, 2019 – The Tecan Group (SIX Swiss Exchange: TECN) today announced that it will present at the following investor conferences in May: UBS Global Healthcare Conference, New York, USA Date: [...]
Vaccinex Announces Poster Presentations at the 2019 ASCO Annual Meeting
15/05/2019
Presentations on anti-SEMA4D antibody, pepinemab, in combination with checkpoint inhibitors ROCHESTER, N.Y., May 15, 2019 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company [...]
Vaccinex Reports First Quarter 2019 Financial Results and Provides Corporate Update
15/05/2019
Updated interim data from CLASSICAL-Lung study to be presented at the annual meeting of the American Society of Clinical Oncology (ASCO) in June 2019 Enrollment in Phase 2 SIGNAL Huntington’s disease trial complete; [...]
Ocutrx Sets the Pace for AR Medical Device Technology at Third Annual Medical Devices Innovation Conference
15/05/2019
Ocutrx CEO Michael Freeman Serves as Key Thought Leader for the AR Medical Device Space at Prestigious Event IRVINE, Calif., May 15, 2019 (GLOBE NEWSWIRE) -- Ocutrx Vision Technologies, LLC , an advanced research and [...]
Krystal Biotech to Present at the RBC Capital Markets 2019 Healthcare Conference
15/05/2019
PITTSBURGH, May 15, 2019 (GLOBE NEWSWIRE) -- Krystal Biotech Inc. , (“Krystal”) (NASDAQ: KRYS), a gene therapy company developing medicines to treat dermatological diseases, today announced that Krish S. Krishnan, [...]
Curetis to Hold Annual General Shareholders’ Meeting on June 27, 2019
15/05/2019
Curetis to Hold Annual General Shareholders’ Meeting on June 27, 2019 Amsterdam, the Netherlands, Holzgerlingen, Germany and San Diego, CA, USA, May 15, 2019, 02:00 pm CEST / 08:00 am EDT - Curetis N.V. (the " Company [...]
Blake Insomnia Therapeutics, Inc. (OTC:BKIT) Announces Change in Business Strategy and name change submission to BioHemp International to Focus on a Rollup Strategy in the CBD Market
15/05/2019
NEW YORK, May 15, 2019 (GLOBE NEWSWIRE) -- Blake Insomnia Therapeutics, Inc (OTC: BKIT, “The Company”) announces that it is rebranding and changing its business model to take advantage of the huge opportunity in the [...]
Evelo Biosciences to Present at 2019 RBC Capital Markets Global Healthcare Conference
15/05/2019
CAMBRIDGE, Mass., May 15, 2019 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq: EVLO) (“Evelo”), a clinical stage biotechnology company developing oral biologics that act on cells in the small intestine with [...]
Shockwave Appoints Keith D. Dawkins M.D. as Chief Medical Officer
15/05/2019
SANTA CLARA, Calif., May 15, 2019 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calcified [...]
resTORbio Reports First Quarter 2019 Financial Results and Corporate Update
15/05/2019
Initiated first Phase 3 trial, PROTECTOR 1, of RTB101 in clinically symptomatic respiratory illness; top-line data from two pivotal Phase 3 trials expected in mid-2020 Initiated Phase 1b/2a trial of RTB101 in [...]
Vericel to Present at the 2019 UBS Global Healthcare Conference on Wednesday, May 22, 2019
15/05/2019
CAMBRIDGE, Mass., May 15, 2019 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced cell therapies for the sports medicine and severe burn care markets, today announced that Nick Colangelo, [...]
Langley BC Cannabis Ltd. Launches funding to raise $5 Million from Accredited Investors
15/05/2019
Langley BC Cannabis Ltd. is currently in the early stages of its application to become a medical cannabis producer under Health Canada’s Cannabis Act LANGLEY, British Columbia, May 15, 2019 (GLOBE NEWSWIRE) -- Langley [...]
Dermavant Sciences Appoints Timothy S. Nelson and Kenneth E. Ludlum to Board of Directors
15/05/2019
LONDON, May 15, 2019 (GLOBE NEWSWIRE) -- Dermavant Sciences, a dermatology-focused subsidiary of Roivant Sciences, today announced that Timothy S. Nelson and Kenneth E. Ludlum have been appointed to Dermavant’s Board of [...]
Veritas Announces the Completion of Clinical Trial on their Cannabis Product for Treatment of Acute Pain
15/05/2019
SAN JUAN, Puerto Rico, May 15, 2019 (GLOBE NEWSWIRE) -- Veritas Pharma Puerto Rico, Inc., a wholly owned subsidiary of Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas”), is pleased to announce [...]
Intra-Cellular Therapies Announces Presentations on Lumateperone Schizophrenia Program at the American Psychiatric Association (APA) Annual Meeting
15/05/2019
NEW YORK, May 15, 2019 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, announced the [...]
Rubius Therapeutics Reports First Quarter 2019 Financial Results and Operational Progress
15/05/2019
Enrollment for Phase 1b Trial of RTX-134 for Phenylketonuria on Track for Second Quarter 2019; Initial Clinical Data Anticipated in Second Half 2019 Company Announces Transition of President Torben Straight Nissen, Ph.D [...]
Establishment Labs Reports First Quarter 2019 Financial Results
15/05/2019
NEW YORK, May 15, 2019 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today [...]
Outlook Therapeutics Provides Business Update and Reports Second Quarter Financial Results for Fiscal 2019
15/05/2019
CRANBURY, N.J., May 15, 2019 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (NASDAQ:OTLK) (the “Company”) today reported business highlights and financial results for its second fiscal quarter ended March 31, 2019. [...]

Pages